UK trading ended on a pessimistic note this afternoon as Europe's second largest drugmaker, AstraZen...
UK trading ended on a pessimistic note this afternoon as Europe's second largest drugmaker, AstraZeneca, dropped on fear its cholesterol drug won't receive approval for sale in the US.
Meanwhile, the benchmark FTSE 100 still lingers above the 4,000 mark after losing just 1.20 points today to 4,073.60.
AstraZeneca shed 83p to 2,482p after a report made by US regulators revealed that the drugmaker's Crestor cholesterol drug may drug may pose more of a risk to the kidneys than do similar pills.
BT Group dropped 5.5p to 191p after broker Cazenove & Co. lowered its recommendation on the shares to "long-term buy" from "buy".
Hanover International advanced 14p to 122.5p after Trefick announced it offered to buy the approximately 51% of the company it doesn't already own for 125p a share.
Invensys rose 1.25p to 21.25p after the debt-ridden engineer said it had sold a US-based semiconductor business for $44m.
Kensington Group gained 8.5p to 293p. The mortgage-lender announced first-half net income increased 3% as demand for loans advanced.
Meanwhile, MFI Furniture Group climbed 13.5p to 177.5p.
Signet Group rose 5.75p to 97.5p after the owner of Kay Jewellers stores in North America and H. Samuel in the UK said sales in America improved in the last two months.
And Xstrata climbed 7.25p to 401.5p after an analyst at Deutsche Bank AG reaffirmed coverage of the company with a "buy" recommendation.
On Wall Street, the Dow Jones Industrial Average index is currently down 0.84 points to 9,215.95.
Meanwhile, the S&P 500 index is up 1.50 points to 1,005.92, and Nasdaq's Composite index has so far gained 12.25 points to 1,732.96.
Encouraging better use of tech
Win one of three £20 Amazon vouchers
Vanguard's multi-asset range
Replaces Lesley Titcomb
Through TVC & APTA module